Medication related adverse effects (Asthma/COPD)

PULM_MEDICATIO_COMORB

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
PULM_MEDICATIO_COMORB

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 70921 35603 35318
Unadjusted prevalence (%) 19.93 17.94 22.44
Mean age at first event (years) 68.39 67.69 69.11

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.05 2.88 [2.65, 3.13] <1e-100 15607
15 years 0.01 1.69 [1.57, 1.83] 2.9e-40 7066
5 years 0.00 3.00 [2.81, 3.20] <1e-100 5324
1 year 0.00 5.39 [4.88, 5.95] <1e-100 2043

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: PULM_MEDICATIO_COMORB – Medication related adverse effects (Asthma/COPD)
GWS hits:

Survival analyses between endpoints

Plot

before Medication related adverse effects (Asthma/COPD)
after Medication related adverse effects (Asthma/COPD)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Medication related adverse effects (Asthma/COPD)